Nutritional support and dietary interventions for patients with ulcerative colitis: current insights

References

• Gentschew L, Ferguson LR. Role of nutrition and microbiota in susceptibility to inflammatory bowel diseases. Mol Nutr Food Res. 2012;56(4):524–535.
   PubMed Web of Science ®Google Scholar
• Lukas M, Bortlik M, Maratka Z. What is the origin of ulcerative colitis? Still more questions than answers. Postgrad Med J. 2006; 82(972):620–625.
   Web of Science ®Google Scholar
• Ballegaard M, Bjergstrom A, Brondum S, Hylander E, Jensen L, Ladefoged K. Self-reported food intolerance in chronic inflammatory bowel disease. Scand J Gastroenterol. 1997;32(6):569–571.
   PubMed Web of Science ®Google Scholar
• Jowett SL, Seal CJ, Phillips E, Gregory W, Barton JR, Welfare MR. Dietary beliefs of people with ulcerative colitis and their effect on relapse and nutrient intake. Clin Nutr. 2004;23(2):161–170.
   Web of Science ®Google Scholar
• Green TJ, Issenman RM, Jacobson K. Patients’ diets and preferences in a pediatric population with inflammatory bowel disease. Can J Gastroenterol. 1998;12(8):544–549.
   Google Scholar
• Gray P, Mehr S, Katelaris C, et al. Salicylate elimination diets in children: is food restriction supported by the evidence? Med J Aust. 2013;198(11):600–602.
   Web of Science ®Google Scholar
• Monsbakken KW, Vandvik PO, Farup PG. Perceived food intolerance in subjects with irritable bowel syndrome–etiology, prevalence and consequences. Eur J Clin Nutr. 2006;60(5):667–672.
   Web of Science ®Google Scholar
• Aloi M, Nuti F, Stronati L, Cucchiara S. Advances in the medical management of paediatric IBD. Nat Rev Gastroenterol Hepatol. 2014;11(2):99–108.
   PubMed Web of Science ®Google Scholar
• Tsiountsioura M, Wong JE, Upton J, et al. Detailed assessment of nutritional status and eating patterns in children with gastrointestinal diseases attending an outpatients clinic and contemporary healthy controls. Eur J Clin Nutr. 2014;68(6):700–706.
   Web of Science ®Google Scholar
• Wiskin AE, Wootton SA, Hunt TM, et al. Body composition in childhood inflammatory bowel disease. Clin Nutr. 2011;30(1):112–115.
   Web of Science ®Google Scholar
• Tanaka M, Shibayama T, Sato E, Sasaki S, Kazuma K. Dietary intake and body composition of Japanese ulcerative colitis patients in remission. Gastroenterol Nurs. 2007;30(5):357–362.
   Web of Science ®Google Scholar
• Capristo E, Mingrone G, Addolorato G, Greco AV, Gasbarrini G. Metabolic features of inflammatory bowel disease in a remission phase of the disease activity. J Intern Med. 1998;243(5):339–347.
   Web of Science ®Google Scholar
• Valentini L, Schaper L, Buning C, et al. Malnutrition and impaired muscle strength in patients with Crohn’s disease and ulcerative colitis in remission. Nutrition. 2008;24(7–8):694–702.
   Web of Science ®Google Scholar
• Bryant RV, Ooi S, Schultz CG, et al. Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease. Aliment Pharmacol Ther. 2015;41(9):895–906.
   PubMed Web of Science ®Google Scholar
• Hill RJ, Davies PS. You look all right to me: compromised nutritional status in paediatric patients with ulcerative colitis. J Pediatr Gastroenterol Nutr. 2013;56(4):385–389.
   PubMed Web of Science ®Google Scholar
• Friedman AN, Fadem SZ. Reassessment of albumin as a nutritional marker in kidney disease. J Am Soc Nephrol. 2010;21:223–230.
   PubMed Web of Science ®Google Scholar
• Valentini L, Schulzke JD. Mundane, yet challenging: the assessment of malnutrition in inflammatory bowel disease. Eur J Intern Med. 2011;22(1):13–15.
   Web of Science ®Google Scholar
• Mijac DD, Jankovic GL, Jorga J, Krstic MN. Nutritional status in patients with active inflammatory bowel disease: prevalence of malnutrition and methods for routine nutritional assessment. Eur J Intern Med. 2010;21(4):315–319.
   PubMed Web of Science ®Google Scholar
• Ripoli J, Miszputen SJ, Ambrogini Jr O, Carvalho L. Nutritional follow-up of patients with ulcerative colitis during periods of intestinal inflammatory activity and remission. Arq Gastroenterol. 2010;47(1):49–55.
   Google Scholar
• Gerasimidis K, Barclay A, Papangelou A, et al. The epidemiology of anemia in pediatric inflammatory bowel disease: prevalence and associated factors at diagnosis and follow-up and the impact of exclusive enteral nutrition. Inflamm Bowel Dis. 2013;19(11):2411–2422.
   Web of Science ®Google Scholar
• Sjoberg D, Holmstrom T, Larsson M, Nielsen AL, Holmquist L, Ronnblom A. Anemia in a population-based IBD cohort (ICURE): still high prevalence after 1 year, especially among pediatric patients. Inflamm Bowel Dis. 2014;20(12):2266–2270.
   PubMed Web of Science ®Google Scholar
• Mullin GE. Micronutrients and inflammatory bowel disease. Nutr Clin Pract. 2012;27(1):136–137.
   Web of Science ®Google Scholar
• Lochs H, Dejong C, Hammarqvist F, et al. ESPEN Guidelines on Enteral Nutrition: Gastroenterology. Clin Nutr. 2006;25(2):260–274.
   PubMed Web of Science ®Google Scholar
• Blanck S, Aberra F. Vitamin d deficiency is associated with ulcerative colitis disease activity. Dig Dis Sci. 2013;58(6):1698–1702.
   Web of Science ®Google Scholar
• Pappa HM, Grand RJ, Gordon CM. Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease. Inflamm Bowel Dis. 2006;12(12):1162–1174.
   PubMed Web of Science ®Google Scholar
• Lee JH, O’Keefe JH, Bell D, Hensrud DD, Holick MF. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol. 2008;52(24):1949–1956.
   PubMed Web of Science ®Google Scholar
• Geerling BJ, Badart-Smook A, Stockbrügger RW, Brummer R-JM. Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls. Eur J Clin Nutr. 2000;54:514–521.
   PubMed Web of Science ®Google Scholar
• Janczewska I, Bartnik W, Butruk E, Tomecki R, Kazik E, Ostrowski J. Metabolism of vitamin A in inflammatory bowel disease. Hepatogastroenterology. 1991;38(5):391–395.
   Google Scholar
• Sikora SK, Spady D, Prosser C, El-Matary W. Trace elements and vitamins at diagnosis in pediatric-onset inflammatory bowel disease. Clin Pediatr. 2011;50(6):488–492.
   Web of Science ®Google Scholar
• Dalekos GN, Ringstad J, Savaidis I, Seferiadis KI, Tsianos EV. Zinc, copper and immunological markers in the circulation of well nourished patients with ulcerative colitis. Eur J Gastroenterol Hepatol. 1998;10(4):331–337.
   Web of Science ®Google Scholar
• Ringstad J, Kildebo S, Thomassen Y. Serum selenium, copper, and zinc concentrations in Crohn’s disease and ulcerative colitis. Scand J Gastroenterol. 1993;28(7):605–608.
   PubMed Web of Science ®Google Scholar
• Markel TA, Lou DC, Pfefferkorn M, et al. Steroids and poor nutrition are associated with infectious wound complications in children undergoing first stage procedures for ulcerative colitis. Surgery. 2008;144(4):540–545.
   Web of Science ®Google Scholar
• Brown AC, Rampertab SD, Mullin GE. Existing dietary guidelines for Crohn’s disease and ulcerative colitis. Expert Rev Gastroenterol Hepatol. 2011;5(3):411–425.
   PubMed Web of Science ®Google Scholar
• Wedrychowicz A, Kowalska-Duplaga K, Jedynak-Wasowicz U, et al. Serum concentrations of VEGF and TGF-beta1 during exclusive enteral nutrition in IBD. J Pediatr Gastroenterol Nutr. 2011;53(2):150–155.
   Web of Science ®Google Scholar
• Sturm A, Schulte C, Schatton R, et al. Transforming growth factor-beta and hepatocyte growth factor plasma levels in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2000;12(4):445–450.
   Web of Science ®Google Scholar
• Sambuelli A, Diez RA, Sugai E, et al. Serum transforming growth factor-beta1 levels increase in response to successful anti-inflammatory therapy in ulcerative colitis. Aliment Pharmacol Ther. 2000;14(11):1443–1449.
   Web of Science ®Google Scholar
• Babyatsky MW, Rossiter G, Podolsky DK. Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease. Gastroenterology. 1996;110(4):975–984.
   PubMed Web of Science ®Google Scholar
• Truelove SC. Ulcerative colitis provoked by milk. BMJ. 1961;1(5220):154–160.
   Google Scholar
• Wright R, Truelove SC. A controlled therapeutic trial of various diets in ulcerative colitis. BMJ. 1965;2(5454):138–141.
   Google Scholar
• Bernstein CN, Ament M, Artinian L, Ridgeway J, Shanahan F. Milk tolerance in adults with ulcerative colitis. Am J Gastroenterol. 1994;89(6):872–877.
   Web of Science ®Google Scholar
• Barrett JS, Irving PM, Shepherd SJ, Muir JG, Gibson PR. Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders. Aliment Pharmacol Ther. 2009;30(2):165–174.
   PubMed Web of Science ®Google Scholar
• Mishkin B, Yalovsky M, Mishkin S. Increased prevalence of lactose malabsorption in Crohn’s disease patients at low risk for lactose malabsorption based on ethnic origin. Am J Gastroenterol. 1997;92(7):1148–1153.
   PubMed Web of Science ®Google Scholar
• Walton M, Alaunyte I. Do patients living with ulcerative colitis adhere to healthy eating guidelines? A cross-sectional study. Br J Nutr. 2014;112(10):1628–1635.
   Web of Science ®Google Scholar
• Hwang C, Ross V, Mahadevan U. Popular exclusionary diets for inflammatory bowel disease: the search for a dietary culprit. Inflamm Bowel Dis. 2014;20(4):732–741.
   PubMed Web of Science ®Google Scholar
• Cabre E, Domenech E. Impact of environmental and dietary factors on the course of inflammatory bowel disease. World J Gastroenterol. 2012;18(29):3814–3822.
   Web of Science ®Google Scholar
• Roediger WE. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut. 1980;21(9):793–798.
   PubMed Web of Science ®Google Scholar
• Orel R, Kamhi Trop T. Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease. World J Gastroenterol. 2014;20(33):11505–11524.
   PubMed Web of Science ®Google Scholar
• Kanauchi O, Matsumoto Y, Matsumura M, Fukuoka M, Bamba T. The beneficial effects of microflora, especially obligate anaerobes, and their products on the colonic environment in inflammatory bowel disease. Curr Pharm Des. 2005;11(8):1047–1053.
   Web of Science ®Google Scholar
• Benus RF, van der Werf TS, Welling GW, et al. Association between Faecalibacterium prausnitzii and dietary fibre in colonic fermentation in healthy human subjects. Br J Nutr. 2010;104(5):693–700.
   PubMed Web of Science ®Google Scholar
• Sokol H, Seksik P, Furet JP, et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis. 2009;15(8):1183–1189.
   PubMed Web of Science ®Google Scholar
• James SL, Christophersen CT, Bird AR, et al. Abnormal fibre usage in UC in remission. Gut. 2015;64(4):562–570.
   PubMed Web of Science ®Google Scholar
• Fernandez-Banares F, Hinojosa J, Sanchez-Lombrana JL, et al. Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn’s Disease and Ulcerative Colitis (GETECCU). Am J Gastroenterol. 1999;94(2):427–433.
   PubMed Web of Science ®Google Scholar
• Hallert C, Kaldma M, Petersson BG. Ispaghula husk may relieve gastrointestinal symptoms in ulcerative colitis in remission. Scand J Gastroenterol. 1991;26(7):747–750.
   PubMed Web of Science ®Google Scholar
• Faghfoori Z, Navai L, Shakerhosseini R, Somi MH, Nikniaz Z, Norouzi MF. Effects of an oral supplementation of germinated barley foodstuff on serum tumour necrosis factor-alpha, interleukin-6 and -8 in patients with ulcerative colitis. Ann Clin Biochem. 2011;48(Pt 3):233–237.
   Google Scholar
• Kanauchi O, Suga T, Tochihara M, et al. Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial. J Gastroenterol. 2002;37 (Suppl)14:67–72.
   Google Scholar
• Casellas F, Borruel N, Torrejon A, et al. Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin. Aliment Pharmacol Ther. 2007;25(9):1061–1067.
   PubMed Web of Science ®Google Scholar
• Federico A, Tuccillo C, Grossi E, et al. The effect of a new symbiotic formulation on plasma levels and peripheral blood mononuclear cell expression of some pro-inflammatory cytokines in patients with ulcerative colitis: a pilot study. Eur Rev Med Pharmacol Sci. 2009;13(4):285–293.
   Web of Science ®Google Scholar
• Furrie E, Macfarlane S, Kennedy A, et al. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut. 2005;54(2):242–249.
   PubMed Web of Science ®Google Scholar
• Hallert C, Bjorck I, Nyman M, Pousette A, Granno C, Svensson H. Increasing fecal butyrate in ulcerative colitis patients by diet: controlled pilot study. Inflamm Bowel Dis. 2003;9(2):116–121.
   PubMed Web of Science ®Google Scholar
• Wedlake L, Slack N, Andreyev HJ, Whelan K. Fiber in the treatment and maintenance of inflammatory bowel disease: a systematic review of randomized controlled trials. Inflamm Bowel Dis. 2014;20(3):576–586.
   PubMed Web of Science ®Google Scholar
• Copaci I, Chira C, Rovinaru I, Micu L. Maintenance of remission of ulcerative colitis (UC): mesalamine, dietary fiber, S. Boulardi. Dig Liver Dis. 2000;32(Suppl 1):A24.
   Google Scholar
• Welters CF, Heineman E, Thunnissen FB, van den Bogaard AE, Soeters PB, Baeten CG. Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis. Dis Colon Rectum. 2002;45(5):621–627.
   PubMed Web of Science ®Google Scholar
• Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol. 2011;106(4):563–573.
   PubMed Web of Science ®Google Scholar
• Hart AR, Luben R, Olsen A, et al. Diet in the aetiology of ulcerative colitis: a European prospective cohort study. Digestion. 2008;77(1):57–64.
   Web of Science ®Google Scholar
• Sung MK, Park MY. Nutritional modulators of ulcerative colitis: clinical efficacies and mechanistic view. World J Gastroenterol. 2013; 19(7):994–1004.
   Web of Science ®Google Scholar
• Wardlaw GM, Insel PM. Perspectives in Nutrition. 3rd ed. St. Louis: Mosby-Year Book, Inc; 1996.
   Google Scholar
• Kromann N, Green A. Epidemiological studies in the Upernavik district, Greenland: incidence of some chronic diseases. Acta Med Scand. 1980;208:401–406.
   PubMed Web of Science ®Google Scholar
• Davies P, Bailey PJ, Goldenberg M, Ford-Hutchinson AW. The role of arachidonic acid oxygenation products in pain and inflammation. Ann Rev Immunol. 1984;2:335–357.
   PubMed Web of Science ®Google Scholar
• Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME, Smith JH. Leukotriene B, a potent chemotactic and aggregating substance released from polymorphonuclear leukocytes. Nature. 1984;266:264–265.
   Google Scholar
• Lauritsen K, Laursen LS, Bukhave K, Rask-Madsen J. Effects of topical 5-aminosalicylic acid and prednisolone on prostaglandin E2, and leukotriene B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis. Gastroenterology. 1986;91:837–844.
   PubMed Web of Science ®Google Scholar
• Lorenz R, Weber PC, Szimnau P, Heldwein W, Strasser T, Loeschke K. Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease–a randomised, placebo-controlled, double-blind cross-over trial. J Intern Med. 1989;225(Suppl 1):225–232.
   Google Scholar
• Endres S, Ghorbani R, Kelly VE, et al. The effect of dietary supplementation with n-3 fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. New Eng J Med. 1989;320:265–270.
   PubMed Web of Science ®Google Scholar
• Cabre E, Manosa M, Gassull MA. Omega-3 fatty acids and inflammatory bowel diseases–a systematic review. Br J Nutr. 2012;107(Suppl 2): S240–S252.
   Google Scholar
• Grimstad T, Berge RK, Bohov P, et al. Salmon diet in patients with active ulcerative colitis reduced the simple clinical colitis activity index and increased the anti-inflammatory fatty acid index--a pilot study. Scand J Clin Lab Invest. 2011;71(1):68–73.
   PubMed Web of Science ®Google Scholar
• Suskind DL, Wahbeh G, Burpee T, Cohen M, Christie D, Weber W. Tolerability of curcumin in pediatric inflammatory bowel disease: a forced-dose titration study. J Pediatr Gastroenterol Nutr. 2013;56(3):277–279.
   PubMed Web of Science ®Google Scholar
• Lahiff C, Moss AC. Curcumin for clinical and endoscopic remission in ulcerative colitis. Inflamm Bowel Dis. 2011;17(7):E66.
   PubMedGoogle Scholar
• Hanai H, Iida T, Takeuchi K, et al. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol. 2006;4(12):1502–1506.
   PubMed Web of Science ®Google Scholar
• Holt PR, Katz S, Kirshoff R. Curcumin therapy in inflammatory bowel disease: a pilot study. Dig Dis Sci. 2005;50(11):2191–2193.
   PubMed Web of Science ®Google Scholar
• Ramsewak RS, DeWitt DL, Nair MG. Cytotoxicity, antioxidant and anti-inflammatory activities of curcumins I-III from Curcuma longa. Phytomedicine. 2000;7(4):303–308.
   PubMed Web of Science ®Google Scholar
• Venkataranganna MV, Rafiq M, Gopumadhavan S, Peer G, Babu UV, Mitra SK. NCB-02 (standardized Curcumin preparation) protects dinitrochlorobenzene-induced colitis through down-regulation of NFkappa-B and iNOS. World J Gastroenterol. 2007;13(7):1103–1107.
   Web of Science ®Google Scholar
• Magee EA, Edmond LM, Tasker SM, Kong SC, Curno R, Cummings JH. Associations between diet and disease activity in ulcerative colitis patients using a novel method of data analysis. Nutr J. 2005;4:7.
   PubMed Web of Science ®Google Scholar
• Jowett SL, Seal CJ, Pearce MS, et al. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut. 2004;53(10):1479–1484.
   PubMed Web of Science ®Google Scholar
• Roediger WE. Decreased sulphur aminoacid intake in ulcerative colitis. Lancet. 1998;351(9115):1555.
   Web of Science ®Google Scholar
• Herfarth HH, Martin CF, Sandler RS, Kappelman MD, Long MD. Prevalence of a gluten-free diet and improvement of clinical symptoms in patients with inflammatory bowel diseases. Inflamm Bowel Dis. 2014;20(7):1194–1197.
   Web of Science ®Google Scholar
• Gibson PR, Shepherd SJ. Personal view: food for thought–western lifestyle and susceptibility to Crohn’s disease. The FODMAP hypothesis. Aliment Pharmacol Ther. 2005;21(12):1399–1409.
   PubMed Web of Science ®Google Scholar
• Gearry RB, Irving PM, Barrett JS, Nathan DM, Shepherd SJ, Gibson PR. Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease–a pilot study. J Crohns Colitis. 2009;3(1):8–14.
   PubMed Web of Science ®Google Scholar
• Kyaw MH, Moshkovska T, Mayberry J. A prospective, randomized, controlled, exploratory study of comprehensive dietary advice in ulcerative colitis: impact on disease activity and quality of life. Eur J Gastroenterol Hepatol. 2014;26(8):910–917.
   PubMed Web of Science ®Google Scholar